4//SEC Filing
Wirth Edward 4
Accession 0001140361-19-000390
CIK 0001572552other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:02 PM ET
Size
10.9 KB
Accession
0001140361-19-000390
Insider Transaction Report
Form 4
Wirth Edward
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-01-02$0.68/sh−20,440$13,899→ 159,568 total
Holdings
- 192,500
Stock Options
Exercise: $2.34Exp: 2020-03-09→ Common Stock (192,500 underlying) - 120,000
Stock Options
Exercise: $3.64Exp: 2026-02-25→ Common Stock (120,000 underlying) - 150,000
Stock Options
Exercise: $1.95Exp: 2028-03-14→ Common Stock (150,000 underlying) - 50,000
Stock Options
Exercise: $3.90Exp: 2025-02-12→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported.
- [F2]Subject to Mr. Wirth's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was March 14, 2018. The stock options are exercisable upon vesting.
- [F3]Subject to Mr. Wirth's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was March 10, 2013. The stock options are exercisable upon vesting.
- [F4]Subject to Mr. Wirth's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was February 26, 2015. The stock options are exercisable upon vesting.
- [F5]Subject to Mr. Wirth's continued employment with the Company, 25% of the granted stock options vest on the first anniversary of the grant date, and the remaining 75% of the stock options in equal monthly installments over 36 months commencing after the first anniversary of the grant date. The grant date of these options was February 26, 2016. The stock options are exercisable upon vesting.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeother
Related Parties
1- filerCIK 0001532558
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:02 PM ET
- Size
- 10.9 KB